ICW Healthcare Ventures
ICW Ventures is dedicated to uncovering solutions that others could not find, aiming to deliver game-changing health technologies that improve life for everyone. They focus on identifying and developing HealthTech breakthroughs, including innovative vaccines and diagnostic devices, with a mission to create equitable and impactful health solutions.
Industries
Products
EdJen Biotech peptide vaccine platform
A vaccine development platform that identifies conserved pathogen peptides and formulates peptide-only vaccines intended to induce protective immunity while excluding whole pathogen structures or genetic material.
Therapeutic peptide program (MANP analog)
Development of an engineered atrial natriuretic peptide analog intended to activate GC-A receptor pathways, evaluated in first-in-human studies for blood pressure lowering and related cardiometabolic effects.
Portable rapid molecular diagnostic devices (Genomadix)
Development of portable, rapid molecular diagnostic devices aimed at decentralizing molecular testing.
EdJen Biotech peptide vaccine platform
A vaccine development platform that identifies conserved pathogen peptides and formulates peptide-only vaccines intended to induce protective immunity while excluding whole pathogen structures or genetic material.
Therapeutic peptide program (MANP analog)
Development of an engineered atrial natriuretic peptide analog intended to activate GC-A receptor pathways, evaluated in first-in-human studies for blood pressure lowering and related cardiometabolic effects.
Portable rapid molecular diagnostic devices (Genomadix)
Development of portable, rapid molecular diagnostic devices aimed at decentralizing molecular testing.
Services
Venture incubation and project development
Identification and development of early-stage HealthTech projects and ventures, including strategic guidance and project-level support.
CMC and regulatory consulting
Advisory services for chemistry, manufacturing and control (CMC) development, analytical method design, formulation, and preparation for regulatory filings.
Clinical development advisory
Support for early-phase clinical study design and execution, including first-in-human trial planning and safety/tolerability study designs.
Partnership and commercialization development
Facilitation of public-health and industry partnerships and support for commercialization strategy and licensing negotiations.
Venture incubation and project development
Identification and development of early-stage HealthTech projects and ventures, including strategic guidance and project-level support.
CMC and regulatory consulting
Advisory services for chemistry, manufacturing and control (CMC) development, analytical method design, formulation, and preparation for regulatory filings.
Clinical development advisory
Support for early-phase clinical study design and execution, including first-in-human trial planning and safety/tolerability study designs.
Partnership and commercialization development
Facilitation of public-health and industry partnerships and support for commercialization strategy and licensing negotiations.
Expertise Areas
- Peptide-based vaccine development
- Peptide therapeutics development
- Mass spectrometry-based epitope mapping
- Immunogenicity testing and preclinical validation
Key Technologies
- Mass spectrometry (peptide mapping)
- ELISA and immunoassays
- In silico epitope prediction (bioinformatics)
- Peptide engineering